BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report)’s stock price traded down 1% during mid-day trading on Tuesday . The company traded as low as $2.12 and last traded at $2.12. 16,276 shares were traded during mid-day trading, a decline of 82% from the average session volume of 91,642 shares. The stock had previously closed at $2.14.
BeyondSpring Price Performance
The company has a 50-day moving average price of $2.21 and a 200 day moving average price of $2.28.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in BeyondSpring stock. SG Americas Securities LLC bought a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 17,539 shares of the company’s stock, valued at approximately $63,000. 40.29% of the stock is currently owned by hedge funds and other institutional investors.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Featured Stories
- Five stocks we like better than BeyondSpring
- 3 Small Caps With Big Return Potential
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Insider Trading – What You Need to Know
- Insider Buying Signals Upside for These 3 Stocks
- NYSE Stocks Give Investors a Variety of Quality Options
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
